To hear about similar clinical trials, please enter your email below
Trial Title:
Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
NCT ID:
NCT05728125
Condition:
Glioblastoma
Conditions: Official terms:
Glioblastoma
Conditions: Keywords:
Glioblastoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Historically, clinical study participation has been biased toward certain demographics.
However, there is a shortage of studies that delve into the underlying factors that
influence patient participation, both positively and negatively.
Several people will be invited to enroll in this study so that it may collect a variety
of data about glioblastoma clinical trial experiences and identify barriers to
participation as well as the causes of participants' failure or withdrawal.
The data collected from this study will be analyzed and used to improve the experiences
of future glioblastoma patients who are recruited for medical trials.
Criteria for eligibility:
Study pop:
Glioblastoma patients who are actively considering enrolling in an observational clinical
trial, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient has self-identified as planning to enroll in a clinical trial
- Patient has been diagnosed with glioblastoma
- Patient is a minimum of 18 years or older
Exclusion Criteria:
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
March 2024
Completion date:
March 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05728125
